Showing 1,041 - 1,060 results of 18,036 for search 'significant ((((shape decrease) OR (we decrease))) OR (((teer decrease) OR (a decrease))))', query time: 0.65s Refine Results
  1. 1041
  2. 1042
  3. 1043
  4. 1044

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  5. 1045

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  6. 1046

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  7. 1047

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Herein, we reported a facile and green process for fabricating biodegradable and flexible gold ion (Au<sup>3+</sup>)-coordinated cellulose-based light filters with diverse UV- and HEBL-screening capacities via adsorption of Au<sup>3+</sup>. …”
  8. 1048
  9. 1049
  10. 1050

    Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections by Mostafa A. Elfawal (22430138)

    Published 2025
    “…The unexpected SAR of compound <b>15</b> can be explained by computational modeling. We demonstrate the efficacy of optimized compound <b>50</b> as a new oral anthelmintic, which demonstrated better gut restriction properties and significantly reduced the fecundity of T. muris whipworm adults in infected mice. …”
  11. 1051
  12. 1052
  13. 1053
  14. 1054
  15. 1055

    Clinical characteristics of the study population. by Hun Gi Lee (21526538)

    Published 2025
    “…The total number of patients who met with P-TAs was 26,842, with a 43.1% reduction from 17,105–9,737. A decrease was observed across all age groups; however, the rate was lower in the geriatric and severely injured groups. …”
  16. 1056

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  17. 1057

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  18. 1058

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  19. 1059

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  20. 1060